Literature DB >> 35160234

Incidence of Post-Operative Complications and Factors Influencing Their Occurrence in Patients with Sickle Cell Disease in a Low-Income Country: A Case Study of Cameroon.

Dominique Djomo Tamchom1,2,3,4, Charlotte Eposse Ekoube5,6, Basile Essola2,5, Serge Nga Nomo7,8, Fleur Samantha Benghiat2,9, Luc Van Obbergh2,4.   

Abstract

This study aimed to analyse post-operative complications and possible factors influencing their occurrence in the management of patients with sickle cell disease in a low-income country. We prospectively collected data regarding the management of patients with sickle cell disease requiring anesthesia for surgery in 11 Cameroonian hospitals from 1 May 2019 to 30 April 2021. The data were analysed using descriptive statistics and a binary logistic regression was used to determine the dependence between the variables. A total of 124 patients with sickle cell disease were enrolled; 64 were male and 60 female, giving a sex ratio of 0.93. The rate of post-operative complications was 23.4% (29/124) and the death rate was 3.2% (4/124). The female subjects had more complications than the male subjects p < 0.05. The number of vaso-occlusive crises experienced per year showed a significant impact on the occurrence of post-operative complications p < 0.05. Laparoscopic surgery had fewer post-operative complications 5/46 (10.9%) than laparotomy 14/43 (32.5%). The surgical technique for the abdominal procedures had a significant impact on the occurrence of post-operative complications p < 0.05. The type of surgery (p = 0.198) and the anaesthesia technique (p = 0.225) did not show a significant impact on the occurrence of post-operative complications. Particular attention should be paid to female patients with sickle cell disease as they are more likely to experience post-operative complications, as well as to the frequency of vaso-occlusive crises, which are also predictive of post-operative complications. Opting for laparoscopic surgery whenever possible would help to reduce post-operative complications.

Entities:  

Keywords:  anaesthesia; incidence; patient with sickle cell disease; post-operative complications; surgery

Year:  2022        PMID: 35160234      PMCID: PMC8836843          DOI: 10.3390/jcm11030780

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


1. Introduction

Sickle cell (SC) disease is the most common genetic pathology in the world [1]. About 200,000 people are born with this disease each year and the regions with the highest rates are Africa, the Mediterranean, and Asia, where its prevalence is estimated at 2 to 6% of the population [2]. In Cameroon, the prevalence of sickle cell traits is 22.3% and the prevalence of SS homozygous varies from 1.7% to 9%, depending on the region [3]. Despite the complex pathophysiology and the diverse clinical picture, considerable progress has been made in the understanding and management of sickle cell disease [4]. Thanks to improved neonatal screening and treatment, many patients with sickle cell disease survive to adulthood and present themselves more frequently for surgery [2]. It is in this situation that the anaesthesiologist is concerned, especially since 15 to 30% of patients undergoing surgery suffer from post-operative complications [5,6,7]. Surgery exposes the sickle cell disease patient to an increased risk of disease-related complications [8], requiring meticulous perioperative clinical care, including adjusted anaesthesia management, which has been widely described. Most of the data are issued from western countries and only a few from the sub-Saharan area, where facilities are limited, even though they represent most of the SC patients undergoing surgery, suggesting that the data issued from the former countries could be biased [7,9,10]. Therefore, this study is crucial as it contributes to the body of research by analysing post-operative complications and possible factors influencing their occurrence in the perioperative management of sickle cell patients in a low-income country.

2. Methods

After obtaining the ethical clearances from our Institutional Ethics Committee and the National Ethics Committee for Research for Human Health (CNERSH), we prospectively collected data regarding the management of sickle cell patients requiring anesthesia for surgery in 11 Cameroonian hospitals from 1 May 2019 to 30 April 2021. The pre-determined data collection sheet was handled by anaesthesiologists working in hospitals (11) classified as levels 1 and 2 (the highest levels of the health pyramid in Cameroon), from t pre-anaesthetic consultation to post-anaesthetic follow-up. Only facilities with at least one fully qualified anaesthesiologist were included, given the limited number of anaesthesiologists practicing throughout the territory, which was about 50 physicians per 25 million inhabitants in 2019. The classification of risk (minor, intermediate, and high) according to the type of surgery was performed and associated with each collection sheet. All patients with major sickle cell syndrome (referring to more or less severe clinical manifestations, characterised by SS homozygosity and SC composite heterozygosity) admitted to one of the targeted health facilities, who had been under the care of an anaesthesiologist and had undergone surgery, were included in this study. The major sickle cell syndrome combines three main categories of clinical manifestations: chronic haemolytic anaemia; extreme susceptibility to infections; and vaso-occlusive phenomena. It differs from asymptomatic (AS) forms. Those who did not undergo surgery and those who withdrew their consent were excluded. The characteristics of the patients with sickle cell disease were determined using the patients’ medical records or by the patients’ reports when records were not available. The post-operative complications that occurred were recorded as well. Post-operative complications were those that occurred between the end of surgery and post-operative discharge or those that required patients to return to the hospital within 15 days of discharge. Mortality was defined perioperatively. We then looked at the factors that could influence the occurrence of these complications in this study population. As already described, the data were collected on a previously determined sheet, and as such, the main variables were: regular treatment with Hydroxyurea, number of vaso-occlusive crises experienced per year, level of risk associated with surgery, pre-operative transfusion, length of hospital stay before surgery, type of surgery, duration of surgery, surgical technique, ASA classification, context of surgery, and type of anaesthesia. We used convenience sampling to obtain a size sample (Figure 1).
Figure 1

CONSORT 2010 Flow Diagram.

The statistical analysis was performed using IBM SPSS version 23 software (International Business Machines Corporation, New York state, USA). The results were expressed as a percentage number and as an average standard deviation and interval. Binary logistic regression was used to determine the dependence between the variables. The rules of thumb of the binary logistic regression for this study stats that significant variables have a significant impact on the occurrence of post-operative complications in a patient with sickle cell and variables that are not significant do not have a significant impact on the occurrence of post-operative complications. A value of p < 0.05 represents a statistically significant dependence at the 5% level.

3. Results

A total of 124 patients with sickle cell disease were enrolled; 64 were male and 60 female, giving a sex ratio of 0.93. The rate of post-operative complications was 23.4% (29/124) and the death rate was 3.2% (4/124). The mean age of the population was 20.5 ± 7.1 years, with a minimum and maximum of 5 and 47 years, respectively. The mean number of vaso-occlusive crises experienced per year was 2.1 ± 1.1, with a minimum and maximum vaso-occlusive crisis of 1 and 5, respectively. The mean length of pre-operative hospital stay was 2.1 ± 1.4 days, with a minimum and maximum of 1–14 days, respectively. The other characteristics of the study population are listed in Table 1.
Table 1

Characteristics of the study population.

Total Number of Patients = 124Number (n)Percentage (%)
Genotype
SS11290
SC1210
Usual follow-up
Follow-up by a haematologist2419.3
Follow-up by another physician4435.5
On Hydroxyurea2621
Pre-operative transfusion10080.6
ASA classification
ASA210181.5
ASA32318.5
Type of anaesthesia
General anaesthesia8367
Loco-regional anaesthesia4133
Level of risk associated with surgery
Intermediate11996
High54
Surgical context
Emergency surgery1713.7
Elective surgery10786.3
Type of surgery
Digestive surgery7359
Orthopedic surgery3024
Obstetrical surgery1613
Otolaryngology surgery54
Surgical technique
laparotomy4334.7
Laparoscopy4637.1
Others3528.2
Post-operative complications recorded
Fever1613
Vaso-occlusive crisis1512.1
Acute chest syndrome32.4
Deglobalization with severe anaemia54
Parietal suppuration54
Eclampsia of post-partum21.6
Considering the type of surgery in our overall study population, the rate of post-operative complications was higher after orthopaedic surgery 9/30 (30%). Those who underwent laparoscopic surgery for abdominal procedures had fewer post-operative complications 5/46 (10.9%) than those who underwent laparotomy 14/43 (32.5%). Patients with sickle cell disease who received locoregional anaesthesia had more post-operative complications 12/41 (29.3%) than those who received general anaesthesia 17/83 (20.5%). Female subjects had more complications than male subjects p < 0.05. The number of vaso-occlusive crises experienced per year showed a significant impact on the occurrence of post-operative complications p < 0.05. The length of pre-operative hospital stay (p = 1) and pre-operative transfusion (p = 0.989) had no impact on the occurrence of post-operative complications. Emergency surgery (p = 0.721) and anaesthesia technique (p = 0.225) did not have a significant impact on the occurrence of post-operative complications. The type of surgery (p = 0.198) and the duration of surgery (p = 0.194) did not show a significant impact on the occurrence of post-operative complications. The surgical technique used for the abdominal procedures had a significant impact on the occurrence of post-operative complications (p < 0.05). The data from the logistic regression are presented in Table 2.
Table 2

Logistic regression dependence between the variables.

VariablesCoefficientE.SWaldddlSig.Exp(B)
Sex−1.431 **0.5796.10410.0130.239
On Hydroxyurea−0.3580.7000.26210.6090.699
Number of VOC per year0.499 **0.2394.37310.0371.647
ASA classification0.3380.7920.18210.6701.402
Emergency context0.2910.8130.12810.7211.338
Length of pre-operative hospital stay−22.55040,192.7170.00011.0000.000
Pre-operative transfusion−0.0090.6660.00010.9890.991
Type of surgery1.8731.4541.65910.1986.507
Surgical technique1.664 **0.7175.39110.0205.280
Anesthesia technique−0.8190.6751.47110.2250.441
Duration of surgery0.0270.0211.68410.1941.028
Constant 17.26940,192.7170.00011.00031,620,578.337
Classification Table 81.5%
Log likelihood 108.697
Cox and Snell R-square 0.190
Nagelkerke R-square 0.287
Khi-Square26.194 0.051

** are significant at 5%.

4. Discussion

To the best of our knowledge, very few, if any, recent studies have addressed the issue of post-operative complications in patients with sickle cell disease in a diverse population of children and adults simultaneously and for a variety of surgical indications. This study showed that the post-operative complications and their incidences observed in carriers of major sickle cell syndrome in a resource-limited setting were no different from those seen elsewhere. Length of pre-operative hospital stay, pre-operative blood transfusion, emergency context, type of surgery, and type of anaesthesia did not have a significant impact on the occurrence of these complications. However, gender, number of vaso-occlusive crises experienced per year, and surgical technique used influenced the occurrence of post-operative complications.

5. Incidence of Post-Operative Complications in Sickle Cell Patients

The post-operative period is particularly critical, with the highest incidence of complications [11]. The main complications (febrile episodes, haemolysis, vaso-occlusive crisis, thromboembolic accidents, and acute chest syndrome) are characterised by hypoxia, hypothermia, and pain [12,13]. Their incidence varies according to the type of procedure and the medical-surgical team. The treatment is based on adequate hydration, oxygen therapy, broad-purpose antibiotic therapy, or even erythrocyte transfusion. All these complications were observed in our series, independently of the type of surgery performed. The overall incidence of post-operative complications of 23.4% found here is close to that reported by some authors, although most of these authors dealt with only one type of surgery. In the series of laparoscopic cholecystectomy in sickle-cell-disease adults performed between 1996 and 2006 in Saudi Arabia [14], 31/427 (7.3%) of patients had complications, including 19/31 (4.5%) vaso-occlusive seizures; 8/31 (1.9%) acute chest syndromes; 4/31 (0.9%) cases of superficial infection of the surgical wound; and no deaths. In another series of 42 laparoscopic cholecystectomies performed in Senegal [7] between 1998 and 2002, the overall rate of complications noted was 16.7%, with 3 cases (7.1%) of vaso-occlusive crises; 2 cases (4.7%) of acute chest syndrome; 2 (4.7%) cases of post-operative infection; and no deaths. In 138 orthopaedic procedures performed on 118 patients with sickle cell disease in a multicentre study [15], there was an overall rate of 67% of serious complications, and sickle cell events (acute chest syndrome or vaso-occlusive crisis) occurred in 17% of cases. Two patients (1.7%) died following surgery. In a series of cholecystectomies in patients with sickle cell disease in Jamaica [16], the mortality rate was 7.4%. The results observed in these studies are comparable to ours, in which the complications recorded and their proportions are practically the same. However, it should be noted that there were no deaths in the Saudi Arabian and Senegalese cholecystectomy series. In the orthopaedic surgery multicentre series, the death rate was less than half of ours and in the Jamaican cholecystectomy series, the death rate was double ours. As already mentioned, the previous studies focused only on one type of surgery in patients with sickle cell disease. We included different indications for surgery to analyse the influence of this factor on the incidence of post-operative complications in patients with sickle cell disease.

6. Elements That Did Not Have a Significant Impact on the Occurrence of Post-Operative Complications

The pre-operative clinical condition of patients with sickle cell disease may require extensive preparation in advance, since these patients are admitted to hospital for elective surgery several days or weeks before the procedure. However, in our study, the length of pre-operative hospital stay was not a predictive factor for the occurrence of post-operative complications, where the maximum observed pre-operative length of stay was 2 weeks. This is in line with the results reported by some authors. A review of a series of patients with sickle cell disease who underwent cholecystectomy between 1978 and 1991 to assess their perioperative management and clinical outcome [17] showed that these patients were pre-operatively prepared over 2 to 8 weeks, and there were no apparent sickle cell-disease-related vaso-occlusive events or late complications. Although there is currently no consensus on the benefit of pre-operative transfusion for patients with major sickle cell syndrome [18], their anaesthesia preparation frequently includes the transfusion of red blood cells to reduce the risk of morbidity and mortality associated with the procedure [19]. The purpose of blood transfusion in sickle cell disease is to rapidly decrease the proportion of red blood cells containing haemoglobin S, and thus to prevent harmful pathophysiological cascades. In a study conducted in a reference centre for genetic red blood cell diseases [18], on patients with major sickle cell disease syndrome who underwent cholecystectomy between January 2009 and March 2012, there was no difference in complication rates between the transfused and non-transfused groups. In a cohort of paediatric patients with sickle cell disease undergoing abdominal surgery [20], there was no clear association between post-operative complications and transfusion approach or pre-operative haematocrit level. These results are similar to those in our series. Controversy continues regarding whether and when (pre-operatively or post-operatively) patients with sickle cell disease should receive transfusions and which anaesthetic technique (regional or general) confers benefits [2]. The anaesthetic management of patients with sickle cell disease is well defined [4,21]. Compliance with safety rules is essential as in any form of anaesthesia, general or loco-regional. No specific drug protocol is recommended. Our study showed more frequent use of general anesthesia in these patients. This could be due to the choices and habits of anaesthesiologists, but also to the predominant type of surgery, which was abdominal and, most frequently laparoscopic. However, 13% of the surgeries performed were caesarean sections. Opinions still vary as to the choice of anaesthetic technique for a parturient with sickle cell disease. Camous et al., in a study to determine the impact of anaesthetic technique on the occurrence of postnatal complications related to sickle cell disease, suggested that general anaesthesia may be associated with post-natal sickle cell complications, even when the severity of the disease has been taken into account [22]. Bakri et al., on the other hand, suggested that spinal anaesthesia may have advantages over general anaesthesia in parturients with sickle cell disease undergoing caesarean section [23]. Loco-regional anaesthesia is of particular interest and could be recommended for caesarean anaesthesia because providing a sympathetic block leads to vasodilation and increased peripheral microcirculatory flow rates and, thus, probably prevents vaso-occlusive events. Despite this apparent advantage of loco-regional anaesthesia, in our study, we did not observe a statistically significant difference between this anaesthesia technique and general anesthesia in terms of the occurrence of post-operative complications, regardless of the type of surgery, although the patients who received locoregional anaesthesia had more post-operative complications than those who received general anaesthesia (Figure 2).
Figure 2

Incidence of post-operative complications according to the type of anaesthesia.

The type of surgery could also be associated with the risk of post-operative complications. Griffin et al. conducted a retrospective study of 54 children undergoing 66 elective surgical procedures without pre-operative blood transfusion, and 10 children undergoing 10 elective procedures with pre-operative blood transfusion, over 16 years [24]. They found that patients who underwent laparotomy, thoracotomy, or tonsillectomy and adenoidectomy had a higher risk of developing post-operative complications. Contrary to this study, in our series, the type of surgery after which there were the most post-operative complications was orthopaedic surgery. There was no significant difference in impact between the type of surgery and the occurrence of post-operative complications. The perioperative risk for patients with sickle cell disease is thought to be greatly increased in an emergency setting. The urgent nature of the surgery associated with other factors, such as hypoxia, hypothermia, dehydration, acidosis, and pain, increases the incidence of sickling in red blood cells [13]. In a large cohort of paediatric patients (813) with sickle cell disease undergoing abdominal surgery, urgent surgical procedures had almost twice the risk of complications as elective procedures [20]. These results contrast with ours, in which the context of surgical urgency was not predictive of post-operative complications, although the frequency of urgent surgeries was almost similar, with 13.7% in ours and 13% in theirs.

7. Elements That Had a Significant Impact on the Occurrence of Post-Operative Complications

Once the diagnosis of sickle cell disease is made at any time, it is important to organize the modalities of follow-up and management [25], which are focused on hydration, vaccination, pneumococcal antibiotic prophylaxis with penicillin V, systematic supplementation with folic acid, and hydroxycarbamide in case of repeated complications [26,27]. This follow-up could affect the patient’s condition before surgery and most likely the occurrence of post-operative complications. A study conducted between January 2009 and March 2012 on patients with sickle cell disease who had undergone cholecystectomy [18] showed that among the factors studied, a history of acute chest syndrome was associated with the occurrence of post-operative complications. In our study, the number of vaso-occlusive crises experienced per year was a significant predictor of the occurrence of post-operative complications. On one hand, this may imply that reducing the frequency of vaso-occlusive crises in patients with sickle cell disease should reduce the occurrence of post-operative complications but, on the other hand, this is also a warning that these patients should be more closely monitored post-operatively. The surgical technique in our series was associated with post-operative complications, especially for abdominal surgical procedures. Patients who underwent laparoscopic surgery had fewer post-operative complications than those who underwent laparotomy (Figure 3). Laparoscopic surgery, particularly cholecystectomy, is considered a standard operative procedure, especially for gallstone disease (which is common in sickle cell disease). However, although many studies have been published on the benefits and complications of laparoscopic cholecystectomy in lithiasis cholecystitis [9,28,29,30], the evidence for the safety and efficacy of laparoscopy in the management of cholelithiasis in paediatric patients with sickle cell disease remains limited, and related controversies are unresolved. Moreover, laparoscopic surgery is not yet fully available in sub-Saharan African countries and training programs should be more intensively developed, which is now the case in Douala, Cameroon.
Figure 3

Incidence of post-operative complications according to surgical technique.

Our study had limitations. The types of surgery were varied in different proportions, and with different levels of risk. This could constitute a bias in the expression of certain characteristics of the less-represented procedures.

8. Conclusions

Sickle cell disease causes life-threatening complications in the peri-operative period and is of great interest to the anaesthetist. Although practices in the routine follow-up and perioperative management of sickle cell patients in resource-limited settings differ from those in high-resource settings, the incidence of post-operative complications and the complications encountered are not significantly different. Particular attention should be paid to female patients with sickle cell disease as they are more likely to experience post-operative complications, as well as to the frequency of vaso-occlusive crises, which are also predictive of post-operative complications. Pre-operative blood transfusion alone is not sufficient to reduce the occurrence of post-operative complications. Better management of sickle cell disease outside the acute phases, combined with the choice of laparoscopy as far as possible during abdominal surgical procedures, would make it possible to reduce the occurrence of post-operative complications.
  26 in total

1.  Laparoscopic cholecystectomy in children with chronic hemolytic anemia. Is the outcome related to the timing of the procedure?

Authors:  G Currò; G Iapichino; C Lorenzini; R Palmeri; E Cucinotta
Journal:  Surg Endosc       Date:  2005-12-28       Impact factor: 4.584

2.  Preoperative transfusion in sickle cell disease: a survey of practice in England.

Authors:  Jackie Buck; Angela Casbard; Charlotte Llewelyn; Tony Johnson; Sally Davies; Lorna Williamson
Journal:  Eur J Haematol       Date:  2005-07       Impact factor: 2.997

Review 3.  Perioperative considerations for patients with sickle cell disease: a narrative review.

Authors:  Narjeet Khurmi; Andrew Gorlin; Lopa Misra
Journal:  Can J Anaesth       Date:  2017-04-28       Impact factor: 5.063

4.  Anesthetic management of pregnant women with sickle cell disease--effect on postnatal sickling complications.

Authors:  Julien Camous; Aya N'da; Maryse Etienne-Julan; François Stéphan
Journal:  Can J Anaesth       Date:  2008-05       Impact factor: 5.063

5.  Laparoscopic cholecystectomy in 427 adults with sickle cell disease: a single-center experience.

Authors:  Abdulrahman S Al-Mulhim; Abdulmohsen A Al-Mulhim
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

6.  Laparoscopic cholecystectomy in sickle cell patients in Niger.

Authors:  Sani Rachid; Lassey James Didier; Mallam Abdou Badé; Chaibou Maman Sani; Abarchi Habibou
Journal:  Pan Afr Med J       Date:  2009-12-06

7.  Laparoscopic cholecystectomy in adult patients with sickle cell disease.

Authors:  Abdulrahman S Al-Mulhim; Mohammed H Alshehri
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-10       Impact factor: 1.719

8.  The role of laparoscopic cholecystectomy in the management of acute cholecystitis in patients with sickle cell disease.

Authors:  Abdulrahman Saleh Al-Mulhim; Faisal Mohammed Al-Mulhim; Abdulmohsen Abdulla Al-Suwaiygh
Journal:  Am J Surg       Date:  2002-06       Impact factor: 2.565

9.  The onset time of atracurium is prolonged in patients with sickle cell disease.

Authors:  Philippe Dulvadestin; Alain Gilton; Philippe Hernigou; Jean Marty
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

10.  Outcome of cranial surgery in Nigerian patients with hemoglobinopathies: A retrospective study.

Authors:  Oluwakemi A Badejo; Olusola K Idowu; James A Balogun; Wuraola A Shokunbi; Simbo D Amanor-Boadu; Matthew T Shokunbi
Journal:  Surg Neurol Int       Date:  2019-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.